SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-004577
Filing Date
2020-03-24
Accepted
2020-03-24 09:21:55
Documents
7
Period of Report
2020-03-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 50975
2 ex3-1.htm EX-3.1 109134
3 ex10-1.htm EX-10.1 228167
4 ex10-2.htm EX-10.2 52430
5 ex10-3.htm EX-10.3 135773
6 ex10-4.htm EX-10.4 292456
7 ex99-1.htm EX-99.1 20626
  Complete submission text file 0001493152-20-004577.txt   890928
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36268 | Film No.: 20736816
SIC: 2835 In Vitro & In Vivo Diagnostic Substances